These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19238081)

  • 1. Presumed arrhythmic death in consecutive survivors of acute myocardial infarction--implications for primary implantable cardioverter defibrillator implantation.
    Holmgren CM; Nyström BM; Karlsson TK; Herlitz JD; Edvardsson NG
    Coron Artery Dis; 2009 Mar; 20(2):155-62. PubMed ID: 19238081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
    Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR.
    Boyé P; Abdel-Aty H; Zacharzowsky U; Bohl S; Schwenke C; van der Geest RJ; Dietz R; Schirdewan A; Schulz-Menger J
    JACC Cardiovasc Imaging; 2011 Aug; 4(8):871-9. PubMed ID: 21835379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia.
    Haugaa KH; Smedsrud MK; Steen T; Kongsgaard E; Loennechen JP; Skjaerpe T; Voigt JU; Willems R; Smith G; Smiseth OA; Amlie JP; Edvardsen T
    JACC Cardiovasc Imaging; 2010 Mar; 3(3):247-56. PubMed ID: 20223421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.
    Barsheshet A; Goldenberg I; Moss AJ; Huang DT; Zareba W; McNitt S; Klein HU; Guetta V
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1237-42. PubMed ID: 21615813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
    Piccini JP; Al-Khatib SM; Myers ER; Anstrom KJ; Buxton AE; Peterson ED; Sanders GD
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):791-8. PubMed ID: 20132397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of defibrillator implantation after myocardial infarction: clinical practice and compliance to guidelines.
    Sjöblom J; Ljung L; Frick M; Rosenqvist M; Frykman V
    Europace; 2012 Apr; 14(4):490-5. PubMed ID: 22117032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of left ventricular ejection fraction after acute myocardial infarction: implications for implantable cardioverter-defibrillator eligibility.
    Sjöblom J; Muhrbeck J; Witt N; Alam M; Frykman-Kull V
    Circulation; 2014 Aug; 130(9):743-8. PubMed ID: 25074505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
    Hohnloser SH; Kuck KH; Dorian P; Roberts RS; Hampton JR; Hatala R; Fain E; Gent M; Connolly SJ;
    N Engl J Med; 2004 Dec; 351(24):2481-8. PubMed ID: 15590950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate variability density analysis (Dyx) for identification of appropriate implantable cardioverter defibrillator recipients among elderly patients with acute myocardial infarction and left ventricular systolic dysfunction.
    Jørgensen RM; Levitan J; Halevi Z; Puzanov N; Abildstrøm SZ; Messier MD; Huikuri HV; Haarbo J; Thomsen PE; Jons C;
    Europace; 2015 Dec; 17(12):1848-54. PubMed ID: 25755288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
    Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart disease.
    Marynissen T; Floré V; Heidbuchel H; Nuyens D; Ector J; Willems R
    Europace; 2014 Jul; 16(7):1069-77. PubMed ID: 24196450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.
    Atary JZ; Borleffs CJ; Liem SS; Bax JJ; van der Hoeven BL; Bootsma M; van der Wall EE; van Erven L; Schalij MJ
    Europace; 2010 Mar; 12(3):378-84. PubMed ID: 20056593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.
    Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Velazquez EJ; Peterson ED; Wang TY
    Circulation; 2017 Jan; 135(1):38-47. PubMed ID: 27881561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When to consider an implantable cardioverter defibrillator following myocardial infarction?
    Szwejkowski BR; Wright GA; Connelly DT; Gardner RS
    Heart; 2015 Dec; 101(24):1996-2000. PubMed ID: 26526420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials.
    Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Marchant B; Camm J
    Eur Heart J; 2005 Jul; 26(14):1385-93. PubMed ID: 15914501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
    Belhassen B; Ohayon-Tsioni T; Glick A; Viskin S
    Isr Med Assoc J; 2009 Sep; 11(9):520-4, 526, 528. PubMed ID: 19960844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.